Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Review Article

Hypertension — still an important cause of heart failure?

Abstract

Hypertension has been the single most important risk factor for heart failure until the last few decades. Now, it is frequently claimed that atherosclerotic coronary artery disease dominates as the major underlying cause, and hypertension is of lesser importance. We here review evidence regarding the contribution of hypertension to heart failure in the recent decades. It is not possible, in our view, to be confident of the relative importance of hypertension and coronary artery disease since there are significant limitations in the available data. The often-questionable diagnostic criteria used in defining heart failure is one such limitation. The absence or inadequacy of blood pressure recordings over the years prior to a diagnosis of heart failure seriously hinders the reaching of firm conclusions in many reports. Extrapolations from aetiological observations in one racial group to those in other racial groups, and from highly selected study groups in tertiary referral centres to patients with heart failure in primary and secondary care, may not be justified. Finally, the situation of heart failure primarily due to impaired left ventricular diastolic function, where hypertension is a frequent precursor, is often ignored in discussions of aetiology. Our view is that hypertension remains and probably is the single most, important modifiable risk factor for cardiac failure in some races and countries, where the dominant cardiac abnormality is left ventricular diastolic dysfunction. The situation is less clear for patients with heart failure primarily due to left ventricular systolic dysfunction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Smirk FH . The clinical manifestations of hypertension. In: Smirk FH (ed). High Arterial Pressure. Blackwell: Oxford, 1957, pp 83–88.

    Google Scholar 

  2. Kannel WB et al. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med 1972; 287: 781–787.

    Article  CAS  PubMed  Google Scholar 

  3. Levy D et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557–1562.

    Article  CAS  PubMed  Google Scholar 

  4. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. JAMA 1967; 202: 1028–1034.

  5. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. JAMA 1970; 213: 1143–1152.

  6. Moser M, Hebert PR . Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214–1218.

    Article  CAS  PubMed  Google Scholar 

  7. Clawson BJ . Incidence of types of heart disease among 30,265 autopsies, with special reference to age and sex. Am Heart J 1941; 22: 607–624.

    Article  Google Scholar 

  8. Wartman WB, Hellerstein HK . The incidence of heart disease in 2,000 consecutive autopsies. Ann Intern Med 1943; 28: 41–65.

    Google Scholar 

  9. Vasan RS, Levy D . The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Arch Intern Med 1996; 156: 1789–1796.

    Article  CAS  PubMed  Google Scholar 

  10. Lloyd-Jones DM et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106: 3068–3072.

    Article  PubMed  Google Scholar 

  11. Haider AW, Larson MG, Franklin SS, Levy D . Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10–16.

    Article  PubMed  Google Scholar 

  12. Kostis JB et al. Association of increased pulse pressure with the development of heart failure in SHEP. Am J Hypertens 2001; 14: 798–803.

    Article  CAS  PubMed  Google Scholar 

  13. Chae CU et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634–639.

    Article  CAS  PubMed  Google Scholar 

  14. Himmelmann A . Hypertension: an important precursor of heart failure. Blood Press 1999; 8: 253–260.

    Article  CAS  PubMed  Google Scholar 

  15. Frohlich ED . Hypertension: our major challenges. Hypertension 2001; 38: 990–991.

    Article  CAS  PubMed  Google Scholar 

  16. Teerlink JR, Goldhaber SZ, Pfeffer MA . An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991; 121: 1852–1853.

    Article  CAS  PubMed  Google Scholar 

  17. Gheorghiade M, Bonow RO . Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation 1998; 97: 282–289.

    Article  CAS  PubMed  Google Scholar 

  18. Johnstone DE et al. Diagnosis and management of heart failure. Can J Cardiol 1994; 10: 613–631.

    CAS  PubMed  Google Scholar 

  19. Petrie MC, Berry C, Stewart S, McMurray JJV . Failing ageing hearts. Eur Heart J 2001; 22: 1978–1990.

    Article  CAS  PubMed  Google Scholar 

  20. He J et al. Risk factors for congestive heart failure in US men and women. Arch Intern Med 2001; 161: 996–1002.

    Article  CAS  PubMed  Google Scholar 

  21. Coronal R, de Groot JR, van Lieshout JJ . Defining heart failure. Cardiovasc Res 2001; 50: 419–422.

    Article  Google Scholar 

  22. Remes J, Miettinen H, Reunanen A, Pyorala K . Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315–321.

    Article  CAS  PubMed  Google Scholar 

  23. Davies MK et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001; 358: 439–444.

    Article  CAS  PubMed  Google Scholar 

  24. Marantz PR, Alderman MH, Tobin JN . Diagnostic heterogeneity in clinical trials for congestive heart failure. Ann Intern Med 1988; 109: 55–61.

    Article  CAS  PubMed  Google Scholar 

  25. Goff DC et al. Congestive heart failure in the United States. Is there more than meets the I(CD Code)? The Corpus Christi Heart Project. Arch Intern Med 2000; 160: 197–202.

    Article  PubMed  Google Scholar 

  26. Psaty BM, Boineau R, Kuller LH, Luepker RV . The potential costs of upcoding for heart failure in the United States. Am J Cardiol 1999; 84: 108–109.

    Article  CAS  PubMed  Google Scholar 

  27. O’Connor CM et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 2000; 86: 863–867.

    Article  PubMed  Google Scholar 

  28. Nicholls MG . Hypertension, hypertrophy, heart failure. Heart 1996; 76(Suppl 3): 92–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Fox KF et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001; 22: 228–236.

    Article  CAS  PubMed  Google Scholar 

  30. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G . Heart failure in the general population of men—morbidity, risk factors and prognosis. J Intern Med 2001; 249: 253–261.

    Article  CAS  PubMed  Google Scholar 

  31. Kupari M et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med 1997; 241: 387–394.

    Article  CAS  PubMed  Google Scholar 

  32. Chobanian AV et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560–2572.

    Article  CAS  PubMed  Google Scholar 

  33. Guidelines Committee. 2003 European Society of Hypertension—European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.

  34. Andersson B, Waagstein F . Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993; 126: 632–640.

    Article  CAS  PubMed  Google Scholar 

  35. Cleland JGF et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002; 360: 1631–1639.

    Article  CAS  PubMed  Google Scholar 

  36. Kitzman DW et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144–2150.

    Article  PubMed  Google Scholar 

  37. Bourassa MG et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993; 22(Suppl A): 14A–19A.

    Article  CAS  PubMed  Google Scholar 

  38. Alexander M et al. Hospitalization for congestive heart failure. JAMA 1995; 274: 1037–1042.

    Article  CAS  PubMed  Google Scholar 

  39. Aronow WS, Ahn C, Kronzon I . Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 1999; 84: 611–612.

    Article  CAS  PubMed  Google Scholar 

  40. Mathew J et al. Etiology and characteristics of congestive heart failure in blacks. Am J Cardiol 1996; 78: 1447–1450.

    Article  CAS  PubMed  Google Scholar 

  41. Vaccarino V et al. Differences between African Americans and whites in the outcome of heart failure: evidence for a greater functional decline in African Americans. Am Heart J 2002; 143: 1058–1067.

    Article  PubMed  Google Scholar 

  42. Sanderson JE, Tse T-F . Heart failure: a global disease requiring a global response. Heart 2003; 89: 585–586.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Obasohan AO, Ajuyah CO . How common is heart failure due to systemic hypertension alone in hospitalized Nigerians? J Hum Hypertens 1996; 10: 801–804.

    CAS  PubMed  Google Scholar 

  44. Amoah AGB, Kallen C . Aetiology of heart failure as seen from a national cardiac referral center in Africa. Cardiology 2000; 93: 11–18.

    Article  CAS  PubMed  Google Scholar 

  45. Sanderson JE et al. The aetiology of heart failure in the Chinese population of Hong Kong—a prospective study of 730 consecutive patients. Int J Cardiol 1995; 51: 29–35.

    Article  CAS  PubMed  Google Scholar 

  46. Agarwal AK, Venugopalan P, de Bono D . Prevalence and aetiology of heart failure in an Arab population. Eur J Heart Fail 2001; 3: 301–305.

    Article  CAS  PubMed  Google Scholar 

  47. Cubillos-Garzon LA, Casas JP, Morillo CA, Bautista LE . Congestive heart failure in Latin America: the next epidemic. Am Heart J 2004; 147: 412–417.

    Article  PubMed  Google Scholar 

  48. Ghali JK . Contemporary issues in heart failure. Am Heart J 1999; 138: 5–8.

    Article  CAS  PubMed  Google Scholar 

  49. Senni M et al. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282–2289.

    Article  CAS  PubMed  Google Scholar 

  50. Masoudi FA et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250–257.

    Article  PubMed  Google Scholar 

  51. Vasan RS, Levy D . Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation 2000; 101: 2118–2121.

    Article  CAS  PubMed  Google Scholar 

  52. Banerjee P et al. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002; 39: 138–141.

    Article  PubMed  Google Scholar 

  53. Angeja BG, Grossman W . Evaluation and management of diastolic heart failure. Circulation 2003; 107: 659–663.

    Article  PubMed  Google Scholar 

  54. Klapholz M et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction. J Am Coll Cardiol 2004; 43: 1432–1438.

    Article  PubMed  Google Scholar 

  55. Yip GWK, Ho PPY, Woo KS, Sanderson JE . Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong. Am J Cardiol 1999; 84: 563–567.

    Article  CAS  PubMed  Google Scholar 

  56. Masoudi FA et al. Gender, age and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003; 41: 217–223.

    Article  PubMed  Google Scholar 

  57. Pilz B, Brasen J-H, Schneider W, Luft FC . Obesity and hypertension-induced restrictive cardiomyopathy. A harbinger of things to come. Hypertension 2004; 43: 911–917.

    Article  CAS  PubMed  Google Scholar 

  58. Macdonald PS, O’Rourke MF . Cardiovascular ageing and heart failure. Med J Aust 1998; 169: 480–484.

    CAS  PubMed  Google Scholar 

  59. Brush JE et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302–1307.

    Article  PubMed  Google Scholar 

  60. Strauer BE . Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 1990; 65: 34G–41G.

    Article  CAS  PubMed  Google Scholar 

  61. Schafer S, Kelm M, Mingers S, Strauer BE . Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20: 1431–1437.

    Article  CAS  PubMed  Google Scholar 

  62. McDonagh TA et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829–833.

    Article  CAS  PubMed  Google Scholar 

  63. Zugck C et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 2002; 39: 1615–1622.

    Article  CAS  PubMed  Google Scholar 

  64. Vogt M, Strauer BE . Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease. Am J Cardiol 1995; 76: 48D–53D.

    Article  CAS  PubMed  Google Scholar 

  65. Frohlich ED . Risk mechanisms in hypertensive heart disease. Hypertension 1999; 34: 782–789.

    Article  CAS  PubMed  Google Scholar 

  66. Scheler S, Motz WH . The inter-relationship between hypertension and ischaemic heart disease. Eur Heart J 1999; 1(Suppl I): I2–I6.

    Google Scholar 

  67. Agabiti-Rosei E, Muiesan ML . Hypertension and the heart: from left ventricular hypertrophy to ischaemia to congestive heart failure. In: Birkenhager WH, Robertson JIS, Zanchetti A (eds). Handbook of Hypertension, Vol. 22. Elsevier: Amsterdam, 2004, pp 339–366.

    Google Scholar 

  68. Kenchaiah S et al. Effect of antecedent hypertension on subsequent left ventricular dilatation after acute myocardial infarction (from the Survival and Ventricular Enlargement Trial). Am J Cardiol 2004; 94: 1–8.

    Article  PubMed  Google Scholar 

  69. Richards AM et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39: 1182–1188.

    Article  PubMed  Google Scholar 

  70. French JK et al. Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension. Am J Cardiol 1993; 71: 505–510.

    Article  CAS  PubMed  Google Scholar 

  71. Natali A et al. Coronary artery disease and arterial hypertension: clinical, angiographic and follow-up data. J Intern Med 2000; 247: 219–230.

    Article  CAS  PubMed  Google Scholar 

  72. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703–713.

  73. Primatesta P, Poulter NR . Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens 2004; 22: 1093–1098.

    Article  CAS  PubMed  Google Scholar 

  74. Lloyd-Jones DM et al. Differential control of systolic and diastolic blood pressure. Factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594–599.

    Article  CAS  PubMed  Google Scholar 

  75. Meissner I et al. Detection and control of high blood pressure in the community. Do we need a wake-up call? Hypertension 1999; 34: 466–471.

    Article  CAS  PubMed  Google Scholar 

  76. Kastarinen MJ et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16: 1379–1387.

    Article  CAS  PubMed  Google Scholar 

  77. Johannesson M . The cost-effectiveness of hypertension in Sweden. Pharmaco Economics 1995; 7: 242–250.

    Article  CAS  Google Scholar 

  78. MacMahon et al. Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.

    Article  CAS  PubMed  Google Scholar 

  79. Collins R et al. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview and randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–838.

    Article  CAS  PubMed  Google Scholar 

  80. Rodgers A, Lawes C, MacMahon S . Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens 2000; 18(Suppl 1): S3–S6.

    CAS  Google Scholar 

  81. Smith SC et al. Principles for national and regional guidelines on cardiovascular disease prevention. A scientific statement from the World Heart and Stroke Forum. Circulation 2004; 109: 3112–3121.

    Article  PubMed  Google Scholar 

  82. Ho KKL et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993; 88: 107–115.

    Article  CAS  PubMed  Google Scholar 

  83. Ho KKL, Pinsky JL, Kannel WB, Levy D . The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22(Suppl A): 6A–13A.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Ms Reena John for secretarial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M G Nicholls.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kazzam, E., Ghurbana, B., Obineche, E. et al. Hypertension — still an important cause of heart failure?. J Hum Hypertens 19, 267–275 (2005). https://doi.org/10.1038/sj.jhh.1001820

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001820

Keywords

This article is cited by

Search

Quick links